DALLA PALMA, ANNA BENEDETTA
 Distribuzione geografica
Continente #
NA - Nord America 555
EU - Europa 429
AS - Asia 166
AF - Africa 15
Continente sconosciuto - Info sul continente non disponibili 2
Totale 1.167
Nazione #
US - Stati Uniti d'America 545
SE - Svezia 127
CN - Cina 109
IE - Irlanda 94
IT - Italia 87
SG - Singapore 37
DE - Germania 32
AT - Austria 15
FR - Francia 15
TR - Turchia 14
FI - Finlandia 13
RO - Romania 12
CI - Costa d'Avorio 11
CZ - Repubblica Ceca 10
CA - Canada 9
BE - Belgio 8
GB - Regno Unito 5
IN - India 4
SC - Seychelles 3
UA - Ucraina 3
EU - Europa 2
NL - Olanda 2
RU - Federazione Russa 2
BG - Bulgaria 1
BZ - Belize 1
KH - Cambogia 1
LU - Lussemburgo 1
NG - Nigeria 1
NO - Norvegia 1
PH - Filippine 1
RS - Serbia 1
Totale 1.167
Città #
Chandler 132
Dublin 94
Ann Arbor 57
Ashburn 52
Boardman 40
Shanghai 37
New York 26
Singapore 24
Beijing 21
Parma 21
Dearborn 19
Bremen 16
Princeton 16
Vienna 15
Wilmington 13
Izmir 12
Abidjan 11
Helsinki 10
Nanjing 10
Brno 8
Brussels 8
Des Moines 7
San Mateo 7
Dallas 6
Fairfield 6
Focsani 6
Romainville 6
Shenyang 6
Toronto 6
Woodbridge 6
Bologna 5
Modena 5
Santa Clara 5
Los Angeles 4
Munich 4
Rho 4
Savignano sul Rubicone 4
West Jordan 4
Cesena 3
Guangzhou 3
Hangzhou 3
Hebei 3
Jinan 3
Milan 3
Nanchang 3
Norwalk 3
Reggio Emilia 3
Rome 3
Seattle 3
Arcevia 2
Borås 2
Changsha 2
Cornaredo 2
Florence 2
Fremont 2
Jacksonville 2
Kocaeli 2
Marseille 2
Medesano 2
Ottawa 2
Piacenza 2
Pune 2
Taiyuan 2
Tianjin 2
Washington 2
Amsterdam 1
Aosta 1
Augusta 1
Belgrade 1
Belize City 1
Castelfranci 1
Castelfranco Emilia 1
Charlotte 1
Chengdu 1
Denver 1
Edinburgh 1
Hefei 1
Huizen 1
Jiaxing 1
Kunming 1
Lagos 1
Leawood 1
Lille 1
Luxembourg 1
Manchester 1
Monmouth Junction 1
Montesilvano 1
Naples 1
Nerviano 1
Oslo 1
Paris 1
Phnom Penh 1
Phoenix 1
Rockville 1
San Francisco 1
Sofia 1
Taizhou 1
Tampa 1
Turku 1
Verona 1
Totale 833
Nome #
Neurofibromatosis type I and multiple myeloma coexistence: A possible link? 94
Bone marrow CX3CL1/Fractalkine is a new player of the pro-angiogenic microenvironment in multiple myeloma patients 92
Novel targets for the treatment of relapsing multiple myeloma 83
Bovine pestivirus is a new alternative virus for multiple myeloma oncolytic virotherapy 80
CD14+CD16+ monocytes are involved in daratumumab-mediated myeloma cells killing and in anti-CD47 therapeutic strategy 78
Bone Marrow DKK-1 Levels in Smoldering Multiple Myeloma Patients: A New Independent Risk Factor for Progression 75
A Rare Case of Systemic AL Amyloidosis with Muscle Involvement: A Misleading Diagnosis 72
PD-L1/PD-1 Pattern of Expression Within the Bone Marrow Immune Microenvironment in Smoldering Myeloma and Active Multiple Myeloma Patients 67
Myeloma Cells Deplete Bone Marrow Glutamine and Inhibit Osteoblast Differentiation Limiting Asparagine Availability 67
Monoclonal and Bispecific Anti-BCMA Antibodies in Multiple Myeloma 61
Lenalidomide Increases Human Dendritic Cell Maturation in Multiple Myeloma Modulating Both Monocyte Differentiation and Mesenchymal Stromal Cell Inhibitory Properties through Ikaros and Casein Kinase 1 Degradation, Respectively 58
CD38 Expression by Myeloma Cells and Its Role in the Context of Bone Marrow Microenvironment: Modulation by Therapeutic Agents 55
Concomitant primary hyperparathyroidism in patients with multiple myeloma: A possible link? 54
Novel Approaches to Improve Myeloma Cell Killing by Monoclonal Antibodies 53
Phase II Trial of Maintenance Treatment With IL2 and Zoledronate in Multiple Myeloma After Bone Marrow Transplantation: Biological and Clinical Results 52
Combining bortezomib to high dose melphalan as conditioning regimen results in the improvement of the response rate in newly diagnosed young multiple myeloma patients 52
The impact of CD56 expression in smoldering myeloma patients on early progression 38
Immune response to SARS-CoV-2 mRNA vaccination and booster dose in patients with multiple myeloma and monoclonal gammopathies: impact of Omicron variant on the humoral response 22
Identification of PSMB4 and PSMD4 as novel target genes correlated with 1q21 amplification in patients with smoldering myeloma and multiple myeloma 16
T(10;11)(P13;P14-21) PICALM-MLLT10 ACUTE LEUKEMIA: CHARACTERIZATION OF TWO CASES WITH DIFFERENT PHENOTYPIC PRESENTATION 15
CD38 expression by plasma cells in extramedullary multiple myeloma 13
PROGNOSTIC VALUE OF CYTOGENETIC ABERRATIONS AND INTRATUMORAL GENETIC HETEROGENEITY IN CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) 12
Identification of clinical-biological features of newly diagnosed early relapse multiple myeloma patients eligible for autologous stem cell transplantation 5
Totale 1.214
Categoria #
all - tutte 5.914
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.914


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202090 0 0 2 3 7 18 13 2 20 18 5 2
2020/2021125 4 3 6 3 29 3 12 13 14 14 9 15
2021/2022134 2 5 9 12 1 2 26 18 6 3 12 38
2022/2023482 62 58 36 42 42 48 24 21 109 11 18 11
2023/2024235 8 17 3 4 22 71 19 7 6 14 19 45
2024/202593 25 31 37 0 0 0 0 0 0 0 0 0
Totale 1.214